Status:

COMPLETED

Hair-Safe Study: Scalp Cooling for Hair Saving in Women Undergoing Chemotherapy

Lead Sponsor:

Medical University Innsbruck

Conditions:

Breast Cancer Female

Alopecia

Eligibility:

FEMALE

18-99 years

Brief Summary

Chemotherapy (CT) is a frequent and well established treatment in women with breast and gynecological tumors. Alopecia is one of the most common side effects of CT seriously impairing patient quality ...

Detailed Description

Scalp cooling using cooling caps has been identified as an effective treatment option against CT-induced alopecia in numerous European countries. Originally, crashed ice was used to cause vasoconstric...

Eligibility Criteria

Inclusion

  • Patients with breast or gynecological cancer planning to undergo CT
  • CT can be neoadjuvant, adjuvant or palliative
  • Up to two lines of CT are allowed. Adjuvant therapy counts as one line
  • CT regime is associated with alopecia
  • CT must be planned for at least 4 cycles of taxane or anthracyline-based CT regimen
  • written informed consent age 18 and older

Exclusion

  • Migraine
  • Cold allergy/Cold Agglutinins/Morbus Raynaud
  • Hematological malignancies (Leukemia, non Hodgkins and other generalized lymphomas)
  • Manifest scalp metastases
  • Overt cognitive impairment
  • Insufficient knowledge of German language
  • Reference Population:
  • Patients with breast or gynecological cancer planning to undergo CT
  • CT can be adjuvant, neoadjuvant or palliative
  • up to two lines of CT are allowed. Adjuvant therapy counts as one line.
  • CT regime is associated with alopecia
  • CT must be planned for at least 4 cycles of taxane or anthracycline-based CT regime
  • Refuse to undergo scalp cooling
  • Patients who have been excluded for the study group for the reason of migraine
  • written informed consent
  • age 18 and older

Key Trial Info

Start Date :

May 18 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 28 2021

Estimated Enrollment :

128 Patients enrolled

Trial Details

Trial ID

NCT04117815

Start Date

May 18 2018

End Date

February 28 2021

Last Update

January 20 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University Innsbruck, Department of Gynaecology and Obstetrics

Innsbruck, Tyrol, Austria, 6020

Hair-Safe Study: Scalp Cooling for Hair Saving in Women Undergoing Chemotherapy | DecenTrialz